Ault Disruptive Technologies Corporation, (NYSE American: ADRT) (the “Company”), a publicly-traded special purpose acquisition company, today announced that its board of directors (the “Board”) has determined to redeem all of its outstanding shares of common stock, par value $0.001 per share (the “public shares”) because the Company will not consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”).
Gresham Worldwide, Inc. (OTCQB: GIGA) (“Gresham” or the “Company”), a provider of high-performance purpose-built electronic solutions for mission critical applications in defense, health care, telecommunications, and transportation industries, and Ault Disruptive Technologies Corporation (NYSE American: ADRT) (“Ault Disruptive”), a special purpose acquisition company, today announced they have entered into a definitive agreement and plan of merger (the “Merger Agreement”). Under the terms of the Merger Agreement, a wholly owned subsidiary of Ault Disruptive will merge with and into Gresham and the holders of the outstanding Gresham shares will receive equity in Ault Disruptive in connection with the business combination (the “Transaction”).
Ault Disruptive Technologies Corporation, a special purpose acquisition company (the “Company”), today announced that in view of the unusual activity in the Company’s stock, the NYSE American, LLC (the “NYSE”) has contacted the Company in accordance with the NYSE’s usual practice and recommended that the Company respond by news release to the unusual activity.
Ault Disruptive Technologies Corporation, a special purpose acquisition company (the “Company”), today announced that it will allow those holders of shares of the Company's common stock originally sold as part of the units issued in its initial public offering that elected by 5:00 p.m. Eastern Time on February 13, 2024 to redeem their common stock in connection with the special meeting of stockholders held yesterday at 12:00 p.m. Eastern time (the “Special Meeting”), to reverse their redemption requests by sending a DTC DWAC (Deposit/Withdrawal At Custodian) request to the Company's transfer agent, Continental Stock & Transfer Company by 4:15 p.m. Eastern Time, Tuesday, February 20, 2024.
Ault Disruptive Technologies Corporation, a special purpose acquisition company (the “Company”), today announced that the NYSE American (the “Exchange”) has accepted the Company’s business plan to regain compliance with the Exchange’s continued listing standards as set forth in Sections 1003(b)(i)(A) and (B) of the NYSE American Company Guide (the “Company Guide”).
Ault Disruptive Technologies Corporation, a special purpose acquisition company (the “Company”), advised that its audited consolidated financial statements in its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the Securities and Exchange Commission on April 4, 2023, contained a going concern explanatory paragraph in the audit opinion from its independent registered public accounting firm. This announcement does not represent any change or amendment to the Company’s financial statements or to its Annual Report on Form 10-K for the fiscal year ended December 31, 2022. Release of this information is required by Section 401(h) and 610(b) of the NYSE American Company Guide.
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private investment positions.
Ault Disruptive Technologies Corporation, a special purpose acquisition company (the “Company”), today announced that it will allow those holders of shares of the Company's common stock originally sold as part of the units issued in its initial public offering that elected by 5:00 p.m. Eastern Time on June 14, 2023 to redeem their common stock (“Redeeming Stockholders”) in connection with the special meeting of stockholders held yesterday at 12:00 Eastern time (the “Special Meeting”), to reverse their redemption requests by sending a DTC DWAC (Deposit/Withdrawal At Custodian) request to the Company's transfer agent, Continental Stock & Transfer Company by 5:00 p.m. Eastern Time today, Friday, June 16, 2023.
U.S. stocks traded mixed this morning, with Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.16% to 34,464.01 while the NASDAQ fell 0.14% to 13,763.40. The S&P 500, also rose, gaining, 0.10% to 4,430.43.
Ault Disruptive Technologies Corporation, a special purpose acquisition company (the “Company”), announced today that on October 20, 2022 it had received a letter (the “Letter”) from the NYSE Regulation indicating that NYSE Regulation has determined to commence proceedings to delist the Company’s warrants from the NYSE American exchange and that trading in the warrants would be suspended immediately. Specifically, NYSE Regulation noted in the Letter that the warrants are no longer suitable for listing based on low selling price levels, pursuant to Section 1003(f)(v) of the NYSE American Company Guide. The Company does not intend to appeal the NYSE Regulation’s determination to delist the warrants.
Ault Disruptive Technologies Corporation (the “Company”) today announced that on April 15, 2022, it filed its Annual Report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Commission. In its Form 10-K, the Company's audited financial statements contained an unqualified audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Company's ability to continue as a going concern.
Ault Disruptive Technologies Corporation, a newly organized blank-check special purpose acquisition company formed as a Delaware corporation, today announced that it closed its initial public offering of 11,500,000 units at an offering price of $10.00 per unit. This includes the exercise in full by the underwriters of their over-allotment option to purchase up to an additional 1,500,000 units. Each unit consists of one share of common stock and three-fourths of one redeemable warrant. Each whole warrant will entitle the holder thereof to purchase one share of common stock at $11.50 per share.
